Transl Neurodegener

ISSN	2047-9158
ISSN-L	-
IUID	98a7748bb2c24deb894c8d7078efd40e
Modified	2023-12-04T14:53:02.951Z
Created	2023-12-04T14:53:02.950Z

Year 2023

PubMed DOI Crossref

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.

Yulug B, Altay O, Li X, ..., Uhlén M, Mardinoglu A

Transl Neurodegener 12 (1) 4 [2023-01-26; online 2023-01-26]

Adil Mardinoglu SciLifeLab Fellow

SciLifeLab Data Centre

Publications 9.5.1